Fundamental Analysis of SCHOLAR ROCK HOLDING CORP(NASDAQ:SRRK) stock

Fundamental Rating

Taking everything into account, SRRK scores 2 out of 10 in our fundamental rating. SRRK was compared to 571 industry peers in the Biotechnology industry. SRRK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SRRK has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SRRK has reported negative net income.

SRRK had a negative operating cash flow in the past year.

In the past 5 years SRRK always reported negative net income.

SRRK had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

SRRK has a Return On Assets of -53.30%. This is comparable to the rest of the industry: SRRK outperforms 46.91% of its industry peers.

SRRK has a Return On Equity of -73.62%. This is comparable to the rest of the industry: SRRK outperforms 56.08% of its industry peers.

		Industry Rank	Sector Rank
ROA	-53.3%
ROE	-73.62%
ROIC	N/A

ROA(3y)-44.72%

ROA(5y)-36.48%

ROE(3y)-67.3%

ROE(5y)-56.04%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

SRRK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SRRK does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for SRRK has been increased compared to 1 year ago.

SRRK has more shares outstanding than it did 5 years ago.

The debt/assets ratio for SRRK is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 15.71 indicates that SRRK is not in any danger for bankruptcy at the moment.

SRRK's Altman-Z score of 15.71 is amongst the best of the industry. SRRK outperforms 89.59% of its industry peers.

A Debt/Equity ratio of 0.22 indicates that SRRK is not too dependend on debt financing.

SRRK's Debt to Equity ratio of 0.22 is on the low side compared to the rest of the industry. SRRK is outperformed by 69.14% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	N/A
Altman-Z	15.71

ROIC/WACCN/A

WACC10.51%

2.3 Liquidity

SRRK has a Current Ratio of 8.80. This indicates that SRRK is financially healthy and has no problem in meeting its short term obligations.

SRRK has a better Current ratio (8.80) than 76.37% of its industry peers.

A Quick Ratio of 8.80 indicates that SRRK has no problem at all paying its short term obligations.

SRRK's Quick ratio of 8.80 is fine compared to the rest of the industry. SRRK outperforms 76.90% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	8.8
Quick Ratio	8.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SRRK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.51%.

SRRK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.

EPS 1Y (TTM)-20.51%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-24.53%

Revenue 1Y (TTM)-100%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 19.35% on average over the next years. This is quite good.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-21.74%

EPS Next 2Y-4.91%

EPS Next 3Y8.6%

EPS Next 5Y19.35%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

SRRK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year SRRK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-4.91%

EPS Next 3Y8.6%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

SRRK does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SCHOLAR ROCK HOLDING CORP

NASDAQ:SRRK (11/25/2024, 7:10:56 PM)

After market: 37.8 +0.08 (+0.21%)

37.72

+7.8 (+26.07%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap3.53B

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-53.3%
ROE	-73.62%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	8.8
Quick Ratio	8.8
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-20.51%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-21.74%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-100%

Revenue growth 3YN/A

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

SCHOLAR ROCK HOLDING CORP (SRRK)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens